Discovering LINC01547: A Non-Coding RNA Molecule as A Potential Drug Target

Target Name: LINC01547

NCBI ID: G84536

Other Name(s): PRED54 | Long intergenic non-protein coding RNA 1547, transcript variant 1 | long intergenic non-protein coding RNA 1547 | C21orf67 | C21orf69

Discovering LINC01547: A Non-Coding RNA Molecule as A Potential Drug Target

LINC01547 (PRED54) is a non-coding RNA molecule that has been identified as a potential drug target (or biomarker) for the treatment of various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, and its potential as a drug have piqued the interest of pharmaceutical companies.

The discovery of LINC01547 (PRED54)

LINC01547 (PRED54) was first identified in 2015 by researchers at the Broad Institute of MIT and Harvard, using a technique called RNA-Seq. RNA-Seq is a technique that allows researchers to quickly and efficiently identify the RNA molecules present in a sample, by sequencing the RNA's base pairs. The Broad Institute's researchers used this technique to identify RNA samples from various human tissues, including blood, brain, and pancreatic samples. They then used bioinformatic tools to identify common patterns in the RNA samples, and used those patterns to identify potential candidates for drug targets.

The unique structure of LINC01547 (PRED54)

The structure of LINC01547 (PRED54) has been determined through various studies, including RNA-Seq and X-ray crystallography. The RNA-Seq data revealed that LINC01547 (PRED54) is a non-coding RNA molecule that consists of 21 RNA modules. Each module is made up of a series of alternating regions of uracils and guanilies, which are known as exons. The exons are then connected to the RNA's 5' and 3' ends, and form a stem-loop structure.

The structure of LINC01547 (PRED54) has several unique features that make it an attractive target for drug research. Firstly, the stem-loop structure is highly conserved across different species, which suggests that it is a robust structural feature that can be used as a target for a wide range of organisms. Secondly, the loops and stem-loop regions of LINC01547 (PRED54) are relatively stable, which suggests that they are resistant to changes in RNA structure that might occur during translation. This stability is important for a drug target to be stable and to have a long shelf life.

The function of LINC01547 (PRED54)

The function of LINC01547 (PRED54) is not yet fully understood, but it is thought to play a role in the regulation of gene expression. LINC01547 (PRED54) is known to interact with the protein known as RNA-binding protein (RBP), which is a protein that binds to RNA and plays a role in regulating gene expression.

LINC01547 (PRED54) has also been shown to interact with the RNA-binding protein, called p16, which is a protein that plays a role in the regulation of cell growth and apoptosis.

The potential as a drug target

The potential as a drug target for LINC01547 (PRED54) has piqued the interest of pharmaceutical companies. LINC01547 (PRED54) has been shown to be a potential drug target in various diseases, including cancer. Studies have shown that LINC01547 (PRED54) can be expressed and translated into proteins in cancer cells, and that it can interact with the proteins known as RBP and p16. These interactions suggest that LINC01547 (PRED54) could be used as a drug target to inhibit the growth and spread of cancer cells.

Another potential use for LINC01547 (PRED54) as a drug target is in the treatment of neurodegenerative diseases, such as Alzheimer's disease. Studies have shown that LINC01547 (PRED54) is expressed in the brains of individuals with Alzheimer's disease, and that it is involved in the regulation of the immune response. This suggests that LINC01547 (PRED54) could be used as a drug target to treat

Protein Name: Long Intergenic Non-protein Coding RNA 1547

More Common Targets